Abdominal aortic aneurysm and its correlation to plasma homocysteine, and vitamins

A A Warsi1, B Davies, G Morris-Stiff

  • 1Royal Glamorgan Hospital, Ynysmaerdy, Llantrisant, Rhondda Cynon Taff, S Wales, UK.

Insights

Elevated homocysteine and lower vitamin B12 levels are linked to abdominal aortic aneurysm (AAA). Further research into vitamin supplementation for vascular disease progression is recommended.

Area of Science:

  • Vascular Biology
  • Nutritional Biochemistry

Background:

  • Hyperhomocysteinemia is a known risk factor for atherosclerotic diseases.
  • The relationship between homocysteine and abdominal aortic aneurysm (AAA) is not well understood.
  • Vitamins B12 and folic acid influence homocysteine levels, but their role in AAA is unexamined.

Purpose of the Study:

  • To investigate the association between plasma homocysteine, serum vitamin B12, folic acid levels, and AAA.
  • To explore the potential role of vitamins in the development or progression of AAA.

Main Methods:

  • A case-control study was conducted with 38 AAA patients and 36 controls.
  • Fasting homocysteine, vitamin B12, and folic acid levels were measured using fluorescence polarization immunoassay (FPIA).

Main Results:

  • AAA patients exhibited significantly higher plasma homocysteine levels (19.4 micromol/L) compared to controls (10.9 micromol/L).
  • A significant proportion of AAA patients (68%) had elevated homocysteine compared to controls (6%).
  • AAA patients showed lower mean serum vitamin B12 levels (332.11 pg/L) than controls (414.33 pg/L).

Conclusions:

  • This study confirms elevated plasma homocysteine and reduced vitamin B12 levels in AAA patients.
  • Vitamin supplementation, potentially lowering homocysteine, may influence vascular disease progression.
  • Clinical trials investigating vitamin supplementation for AAA are warranted.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...